|
Cerdido S, Abrisqueta M, Sanchez-Beltran J, Lambertos A, Castejon-Grinan M, Munoz C, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C, Herraiz C. MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42. Cancer Lett. 2024 Jan 28;581:216484. doi: 10.1016/j.canlet.2023.216484. Epub 2023 Nov 25. PubMed PMID: 38008393.
AÑO: 2024; IF: 9.1
|
38008393
|
Castejon-Grinan M, Albers E, Simon-Carrasco L, Aguilera P, Sbroggio M, Pladevall-Morera D, Ingham A, Lim E, Guillen-Benitez A, Pietrini E, Lisby M, Hickson ID, Lopez-Contreras AJ. PICH deficiency limits the progression of MYC-induced B-cell lymphoma. Blood Cancer J. 2024 Jan 23;14(1):16. doi: 10.1038/s41408-024-00979-y. PubMed PMID: 38253636; PubMed Central PMCID: PMC10803365.
AÑO: 2024; IF: 12.9
|
|
Castejon-Grinan M, Cerdido S, Sanchez-Beltran J, Lambertos A, Abrisqueta M, Herraiz C, Jimenez-Cervantes C, Garcia-Borron JC. Melanoma-associated melanocortin 1 receptor variants confer redox signaling-dependent protection against oxidative DNA damage. Redox Biol. 2024 Jun;72:103135. doi: 10.1016/j.redox.2024.103135. Epub 2024 Mar 26. PubMed PMID: 38565069; PubMed Central PMCID: PMC11002308.
AÑO: 2024; IF: 10.7
|
|
Pladevall-Morera D, Castejon-Grinan M, Aguilera P, Gaardahl K, Ingham A, Brosnan-Cashman JA, Meeker AK, Lopez-Contreras AJ. ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. Cancers (Basel). 2022 Mar 31;14(7):1790. doi: 10.3390/cancers14071790. PubMed PMID: 35406561; PubMed Central PMCID: PMC8997088.
AÑO: 2022; IF: 4.5
|
|
Martinez-Vicente I, Abrisqueta M, Herraiz C, Sires-Campos J, Castejon-Grinan M, Bennett DC, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C. Mahogunin Ring Finger 1 Is Required for Genomic Stability and Modulates the Malignant Phenotype of Melanoma Cells. Cancers (Basel). 2020 Oct 1;12(10):2840. doi: 10.3390/cancers12102840. PubMed PMID: 33019669; PubMed Central PMCID: PMC7599452.
AÑO: 2020; IF: 6.575
|